Multisite, multivendor validation of the accuracy and reproducibility of proton‐density fat‐fraction quantification at 1.5T and 3T using a fat–water phantom
Purpose To evaluate the accuracy and reproducibility of quantitative chemical shift‐encoded (CSE) MRI to quantify proton‐density fat‐fraction (PDFF) in a fat–water phantom across sites, vendors, field strengths, and protocols. Methods Six sites (Philips, Siemens, and GE Healthcare) participated in t...
Saved in:
Published in: | Magnetic resonance in medicine Vol. 77; no. 4; pp. 1516 - 1524 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
Wiley Subscription Services, Inc
01-04-2017
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Purpose
To evaluate the accuracy and reproducibility of quantitative chemical shift‐encoded (CSE) MRI to quantify proton‐density fat‐fraction (PDFF) in a fat–water phantom across sites, vendors, field strengths, and protocols.
Methods
Six sites (Philips, Siemens, and GE Healthcare) participated in this study. A phantom containing multiple vials with various oil/water suspensions (PDFF:0%–100%) was built, shipped to each site, and scanned at 1.5T and 3T using two CSE protocols per field strength. Confounder‐corrected PDFF maps were reconstructed using a common algorithm. To assess accuracy, PDFF bias and linear regression with the known PDFF were calculated. To assess reproducibility, measurements were compared across sites, vendors, field strengths, and protocols using analysis of covariance (ANCOVA), Bland–Altman analysis, and the intraclass correlation coefficient (ICC).
Results
PDFF measurements revealed an overall absolute bias (across sites, field strengths, and protocols) of 0.22% (95% confidence interval, 0.07%–0.38%) and R2 > 0.995 relative to the known PDFF at each site, field strength, and protocol, with a slope between 0.96 and 1.02 and an intercept between −0.56% and 1.13%. ANCOVA did not reveal effects of field strength (P = 0.36) or protocol (P = 0.19). There was a significant effect of vendor (F = 25.13, P = 1.07 × 10−10) with a bias of −0.37% (Philips) and −1.22% (Siemens) relative to GE Healthcare. The overall ICC was 0.999.
Conclusion
CSE‐based fat quantification is accurate and reproducible across sites, vendors, field strengths, and protocols. Magn Reson Med 77:1516–1524, 2017. © 2016 International Society for Magnetic Resonance in Medicine |
---|---|
Bibliography: | Dr. Li Pan is an employee of Siemens Healthcare. The authors also acknowledge GE Healthcare who provides research support to the University of Wisconsin‐Madison, the University of California, San Diego, and Duke University, Philips Healthcare who provides research support to the University of Texas‐Southwestern and Vanderbilt University, and Siemens Healthcare who provides research support to Duke University and Johns Hopkins University. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0740-3194 1522-2594 |
DOI: | 10.1002/mrm.26228 |